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UNRELIABILITY OF FIVE ELUTION 
TECHNIQUES IN AN ATTEMPT TO 




With the description of an antibody called Ne" in 
1981, sup(1,2) the current concept of LW as a three-gene 
system evolved. The gene LW is presently called LW sup(a), 
while Ned, now known to be the antithetical low- 
incidence allele of LW sup(a), is designated LW sub(b). In addi- 
tion, there is an amorphic gene lw. The genotype lwlw 
results in the LW(a-b-) red cell phenotype. Three alloan- 
tibodies have been described: anti-LW sup(a), anti-LW sup(b), and 
anti-LW sup(ab). A detailed description of the LW system is 
given by Issitt. sup(3) 
During the past 20 years, a number of reports have 
cited autoanti-LW as a cause of autoimmune hemolytic 
anemia. sup(4-7) The patients in these studies had a positive 
direct antiglobulin test (DAT) and sometimes had 
clinical signs of hemolytic anemia. In 1971, Chown 
et al sup(8) described several patients whose red blood cell 
(RBC) LW antigens were transiently depressed and 
autoanti-LW (anti-LW sup(a)) was detected in their serum. As 
the LW antigen on their RBCs increased, the patients 
developed a positive DAT, but there was no evidence 
of hemolytic anemia and they were successfully 
transfused with LW-positive blood. 
In general, Rh-positive RBCs react more strongly 
with LW antibodies than Rh-negative RBCs. Therefore, 
serologically, anti LW may mimic anti-D. Testing with 
cord RBCs can rule out anti-D, since anti-LW reacts 
equally well with cord cells of all Rh phenotypes and 
the reactions are usually stronger than with adult 
cells.9 It has been observed that eluates prepared by 
various techniques from RBCs coated with autoanti- 
LW or alloanti-LW usually fail to yield the expected 
LW sup(a) or LW sup(ab) antibodies. 
Materials and Methods 
Two examples each of alloanti-LW sup(a) and -LW sup(ab) were 
tested in saline, ficin, and LISS at immediate spin (IS), 
37° and indirect antiglobulin test (UT) against adult 
D-positive and D-negative RBCs of varying Rh 
phenotypes, D-positive and D-negative cord RBCs and 
LW-negative and Rh sub(null) RBCs. 
Adsorptions were performed using equal volumes 
of serum and R sub(1)R sub(1) or rr untreated or enzyme-treated 
RBCs. The mixtures were incubated at 37°C for 1 hour. 
The unadsorbed and once adsorbed serums were 
tested by titration against R sub(1)R sub(1), R sup(2)R sup(2), rr, and cord (rr) 
red cells. The results were scored according to 
Marsh. sup(10) 
Direct antiglobulin tests (DAT) were performed on 
the absorbing cells with both polyspecific and 
monospeciftc anti-IgG antihuman globulin serums. The 
DAT was read at IS and after a 5 min incubation. 
Five elution techniques were tested using untreated 
absorbing red cells: 56°C heat, diethyl ether, digitonin 
acid, chloroform, and xylene." 
The eluates were tested against R sup(1)R sup1) and R sup(2)R sup(2) adult 
RBCs, D-positive and D-negative cord RBCs, and LW(a-) 
and LW(a-b-) RBCs in LISS and with ficin-treated cells 
at 37°C and IAT. 
Eleven examples of RBCs exhibiting a positive DAT 
were obtained from patients whose serums con- 
tained autoanti-LW. Eluates were prepared by one or 
more elution methods (ether, digitonin, chloroform). 
Results 
Two serums containing alloanti-LW sup(a) and two con- 
taining alloanti-LW sup(ab) reacted as expected when tested 
against Rh-positive and Rh-negative adult and cord 
RBCs. Reactivity was enhanced by ficin treatment of 
the RBCs. The four serums, when adsorbed with R sub(1)R sub(1) 
or rr untreated or ficin-treated RBCs, showed some loss 
of titer. In no case was reactivity completely 
removed. Table 1 shows typical titers and scores of an 
alloanti-LW sup(a) before and after adsorption with un- 
treated R sup(a)R sup(a) RBCs. 
DATs performed on untreated absorbing RBCs before 
elutions were performed are shown in Table 2. Reac- 
tions ranged from 1-2 + with both polyspecific and 
monospecific antihuman globulin serums. 
Table 1. Titers and scores of alloanti-LW sup(a) before 
and after adsorption with R sub(1)R sub(1) adult RBCs 
Titer 
Unad- Ad- Unad- Ad- 
sorbed sorbed sorbed sorbrd 
Cells serum serum serum 
Adult R sub(1) R sub(1) 4 2 13 5 
8 4 18 10 
rr 4 2 IO 3 
cord rr 16 4 28 14 
R sub(2)R sub(2) 
Table 2. Eluates prepared from untreated R sub(1)R su(1) 
RBCs after incubation with alloanti-LW sup(a) or -LW sup(ab) 
Elution method 
Antibody 56" Chluro- 
specificity DAT* Digitonin Ether form Xylene 
LW sup(a) I +  - - - - - 
LW sup(a) I +  + - - - - 
LW sup(ab) 2 +  - - - - - 
LW sup(ab) 1 +  - - - - - 
- 
*Direct antiglobulin test on absorbing cells 
A total of 20 eluates were performed on the un- 
treated absorbing red cells. Only one yielded an anti- 
LW sup(a) using the digitonin acid elution method (Table 2) .  
The eluted anti-LW sup(a) reacted with LISS and ficin-treated 
RBCs by IAT. 
A total of 17 elution procedures (ten ether, five 
digitonin, and two chloroform) were used on the red 
cells from 11 patients with autoanti-LW sup(a) or -LWT sup(ab). 
Two ether eluates contained anti-LW (Table 3) .  
Discussion 
Elutions are useful in identification of antibodies 
from serums containing multiple specificities, confir- 
mation of antibody specificity, preparation of typing 
sera, confirmation of weak antigens on red cells, iden- 
tification of antibodies causing hemolytic disease of 
the newborn, identification of antibodies that have 
caused transfusion reactions, and investigation of an- 
tibodies from patients with acquired hemolytic 
anemia. sup(3) 
Antibody sensitization occurred as evidenced by the 
positive DAB on the absorbing cells tested prior to elu- 
tion. However, only three LW antibodies were 
recovered in the 37 eluates prepared in this study, one 
in digitonin acid and two in ether. The low recovery 
rate may be due to the low-affinity of LW antibodies 
for corresponding antigen-positive RBCs as suggested 
by the relatively high titer of the adsorbed serums. The 
low recovery rate may also he due to serological inac- 
tivation of antibody by these elution techniques. 
Conventional adsorption and elution techniques may 
not be appropriate for the serologic study of LW 
antibodies. 
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A REAGENT FOR THE CONVERSION 
OF CITRATED OR EDTA PLASMA TO 
SERUM 
Robert J. Eckrich 
Introduction 
Although serum or plasma can be used for pre- 
transfusion testing, many blood bank technologists 
prefer to use serum. Small fibrin clots, difficult to 
distinguish from agglutinates, may form when plasma 
is used. High levels of fibrinogen in some plasma 
samples can cause rouleaux formation. The activity 
of certain complement-binding antibodies may not he 
evident in plasma because anticoagulants such as citrate 
or ethylenediamine tetraacetic acid (EDTA) chelate 
calcium and magnesium and thus inhibit complement 
activation. Plasma is not suitable for use in the direct 
microcapillary testing method. 
This report describes a reagent that rapidly converts 
citrated or EDTA-anticoagulated plasma to serum. The 
reagent is inexpensive and is stable at room tempera- 
ture. After the conversion, the activity of complement 
is restored while the reactivity of blood group anti- 
bodies is not diminished. This reagent is similar 
in action to Re/coagulan* a commercial diagnostic 
reagent no longer in production. sup(2) 
Materials and Methods 
Conversion reagent 
The reagent contains 10 percent CaCI sub(2)•2, H sub(2)O, 1 
percent MgCI sub(2), 6 H sub(2)O, and 50 mg/mL kaolin (colloidal 
'Clinton Laboratories, formerly of Santa Monica, CA 
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